Venceslau Hespanhol

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.3K citations · Full text

Medicine, Oncology, Pharmacology +15

Survival predictors in advanced non-small cell lung cancer

Venceslau Hespanhol, Henrique Queiroga, André Magalhães et al. · Lung Cancer · 1995 · 74 citations

Medicine, Oncology, Metastasis +11

<p>COPD: misuse of inhaler devices in clinical practice</p>

A. Araújo, Pedro Teixeira, Venceslau Hespanhol et al. · International Journal of COPD · 2019 · 65 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

COPD: understanding patients’ adherence to inhaled medications

A. Araújo, Pedro Teixeira, Venceslau Hespanhol et al. · International Journal of COPD · 2018 · 59 citations · Full text

Medicine, Pharmacotherapy, Pharmaceutical Compliance +16

Identifying relationships between imaging phenotypes and lung cancer-related mutation status: EGFR and KRAS

Gil Pinheiro, Tânia Pereira, Catarina Dias et al. · Scientific Reports · 2020 · 59 citations · Full text

Medicine, Oncology, Radiology +17